Among the other above-mentioned genes, BCL2 was reported as highly expressed in RRMS patients [51], while STAT3, MYC, JUN, NF-κB, and PTEN were identified as candidate genes for the MS susceptibility [52]. This evidence concerns the gene JUN and myeloid sarcoma.